Hikma Pharmaceuticals PLCEigentümerstruktur
| Preis (-) | 52W Hoch | 52W Tief |
| - GBP | - GBP | - GBP |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - GBP | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 208.950.294 | 27.617 | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Hikma Pharmaceuticals PLC
Mitarbeiter 9.400
Handelsplatz LSE
Ticker Symbol HIK
IPO Datum -
Adresse 10 Portman Square, London, United Kingdom, W1H 6AZ
Webseite https://www.hikma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Mazen Samih Taleb Darwazah | Executive Vice Chairman & Deputy CEO of MENA |
| 2 | Mr. Khalid Walid Hussni Al Nabilsi CPA | Deputy CEO of North America and Europe & Director |
| 3 | Mr. Areb AL KURDI | VP, Group Financial Controller & Acting CFO |
| 4 | Ms. Patricia Bousfield | Chief Information Officer |
| 5 | Mr. Guy Featherstone | Associate Director of Investor Relations |
| 6 | Mr. Samuel Park | General Counsel |
| 7 | Mr. Bassam Wael Rushdi Kanaan CFA, CPA | Executive Vice President of Corporate Development and M&A |
| 8 | Mr. Hussein Omar Arkhagha | Chief People Officer |
| 9 | Ms. Susan Ringdal | Executive Vice President of Strategic Planning & Global Affairs |
| 10 | Ms. Julie Hill | Senior Vice President of Corporate Quality Compliance/Health & Safety |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.